Literature DB >> 21858638

Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges.

Dyah Laksmi Dewi1, Hideshi Ishii, Yoshihiro Kano, Shinpei Nishikawa, Naotsugu Haraguchi, Daisuke Sakai, Taroh Satoh, Yuichiro Doki, Masaki Mori.   

Abstract

A growing body of evidence supports the notion that malignant tumors are heterogeneous and contain diverse subpopulations of cells with unique characteristics including the ability to initiate a tumor and metastasize. This phenomenon might be explained by the so-called cancer stem cell (CSC) theory. Recent technological developments have allowed a deeper understanding and characterization of CSCs. Even though the application of this theory to hematopoietic malignancies and solid tumors holds promise for new ways to treat cancer, it also brings some skepticism. Efficacious therapeutic approaches targeting the CSC population should be explored to overcome therapeutic failure and improve patient outcomes. This review will focus on the intrinsic and extrinsic regulation of CSCs, as well as the development of therapeutic approaches against CSCs, predominantly focusing on gastrointestinal malignancies.

Entities:  

Mesh:

Year:  2011        PMID: 21858638     DOI: 10.1007/s00535-011-0442-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  68 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

2.  miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.

Authors:  W W Hwang-Verslues; P-H Chang; P-C Wei; C-Y Yang; C-K Huang; W-H Kuo; J-Y Shew; K-J Chang; E Y-H P Lee; W-H Lee
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

3.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

Authors:  M A Goodell; M Rosenzweig; H Kim; D F Marks; M DeMaria; G Paradis; S A Grupp; C A Sieff; R C Mulligan; R P Johnson
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

4.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

5.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

6.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

7.  Tumor heterogeneity and drug resistance.

Authors:  D L Dexter; J T Leith
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

8.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

9.  Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted.

Authors:  J W Smit; A H Schinkel; B Weert; D K Meijer
Journal:  Br J Pharmacol       Date:  1998-05       Impact factor: 8.739

10.  Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

Authors:  Stephanie Ma; Kwok Wah Chan; Terence Kin-Wah Lee; Kwan Ho Tang; Jana Yim-Hung Wo; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

View more
  13 in total

1.  Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia.

Authors:  Angela N Bartley; Nila Parikh; Chiu-Hsieh Hsu; Denise J Roe; Julie A Buckmeier; Lynda Corley; Ron A Phipps; Gary Gallick; Peter Lance; Patricia A Thompson; Stanley R Hamilton
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-05

Review 2.  Gastric cancer stem cells: evidence, potential markers, and clinical implications.

Authors:  Daniel Brungs; Morteza Aghmesheh; Kara L Vine; Therese M Becker; Martin G Carolan; Marie Ranson
Journal:  J Gastroenterol       Date:  2015-10-01       Impact factor: 7.527

Review 3.  Inflammation and pancreatic cancer: disease promoter and new therapeutic target.

Authors:  Shin Hamada; Atsushi Masamune; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2013-11-30       Impact factor: 7.527

4.  Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cells.

Authors:  Shimpei Nishikawa; Hideshi Ishii; Naotsugu Haraguchi; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Miyuki Ozaki; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2012-03-22       Impact factor: 2.447

Review 5.  Oligometastases: the new paradigm and options for radiotherapy. A critical review.

Authors:  H Badakhshi; A Grün; C Stromberger; V Budach; D Boehmer
Journal:  Strahlenther Onkol       Date:  2013-03-21       Impact factor: 3.621

6.  Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling.

Authors:  Bin Wang; Jia Liu; Lei Na Ma; Hua Liang Xiao; Ya Zhou Wang; Yan Li; Zhe Wang; Linli Fan; Chunhui Lan; Min Yang; Lu Hu; Yanlin Wei; Xiu Wu Bian; Dongfeng Chen; Jun Wang
Journal:  J Gastroenterol       Date:  2012-11-28       Impact factor: 7.527

Review 7.  Cancer stem cells: the 'heartbeat' of gastric cancer.

Authors:  Guihua Xu; Jie Shen; Xiaohui Ou Yang; Masakiyo Sasahara; Xiulan Su
Journal:  J Gastroenterol       Date:  2012-11-27       Impact factor: 7.527

8.  Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.

Authors:  Dongmei Fan; Baoqi Ren; Xiaojun Yang; Jia Liu; Zhengzheng Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-11-15

9.  Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.

Authors:  Cheng-Lin Wu; Ying-Jui Chao; Ta-Ming Yang; Yi-Ling Chen; Kung-Chao Chang; Hui-Ping Hsu; Yan-Shen Shan; Ming-Derg Lai
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

10.  Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.

Authors:  Yoshihiro Kano; Masamitsu Konno; Katsuya Ohta; Naotsugu Haraguchi; Shimpei Nishikawa; Yoshinori Kagawa; Atsushi Hamabe; Shinichiro Hasegawa; Hisataka Ogawa; Takahito Fukusumi; Yuko Noguchi; Miyuki Ozaki; Toshihiro Kudo; Daisuke Sakai; Taroh Satoh; Masaru Ishii; Eiichi Mizohata; Takeshi Inoue; Masaki Mori; Yuichiro Doki; Hideshi Ishii
Journal:  Mol Clin Oncol       Date:  2013-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.